# SmileFlow Phase 1 — Product Shell Final QA v1

## Status

**PASS — PHASE 1 PRODUCT SHELL COMPLETE**

Date: 2026-08-12

## Scope

Final QA covers the authorized Phase 1 Product Shell only:

1. Application Shell
2. Dashboard
3. Global Patient Search
4. Navigation
5. User / Account Structure
6. Responsive Product Shell behavior across Desktop, Laptop, Tablet, and Mobile

No clinical module redesign or implementation is included.

## Figma target

Page: `11 — Product Shell`

Canonical composition frames:

- Desktop: `387:57` — 1440 × 900
- Laptop: `387:85` — 1280 × 820
- Tablet: `387:113` — 1024 × 900
- Mobile: `387:140` — 390 × 844

## Final QA gates

| Gate | Result |
|---|---|
| Phase 1 scope audit | PASS |
| Precise specification | PASS |
| Read-first Figma preflight | PASS WITH CONDITIONS |
| Explicit implementation authorization | PASS |
| Product Shell implementation | PASS |
| Visual / UX audit | PASS WITH OBSERVATIONS |
| Functional prototype QA | PASS |
| Route destination integrity | PASS |
| Protected-area integrity | PASS |

## Functional QA result

The repaired Product Shell contains 38 audited interaction hotspots.

- 38/38 expected reactions present
- 38/38 expected reactions pass action-type validation
- 38/38 expected destinations exist
- 20/20 route destination frames exist
- 2/2 overlay destinations exist
- Broken route destinations: 0

The Figma inspection validates the stored prototype reaction graph and destination integrity. The available design API does not provide a browser-style click-through runner; therefore this QA does not claim manual browser interaction beyond the reaction graph inspection.

## Responsive result

All four required viewport compositions exist at their authorized dimensions:

- Desktop: PASS
- Laptop: PASS
- Tablet: PASS
- Mobile: PASS

The responsive shell preserves the core product destinations while adapting navigation treatment by viewport.

## Visual / UX observations carried forward

The visual/UX audit recorded observations rather than reopening the design:

1. Desktop/laptop navigation treatment should be experienced before any refinement is proposed.
2. Tablet exposes both a menu surface and bottom navigation; this remains an experience-first observation rather than a defect.
3. Mobile search, navigation, and account affordances should be evaluated through actual use before refinement.

These observations do not block Phase 1 completion.

## Governance checks

Protected and unchanged for this Phase 1 work:

- `06 — Layouts`
- `10 — Baseline Integration`
- existing frozen clinical module compositions
- existing clinical QA pages

HMO / insurance remains explicitly excluded from SmileFlow scope.

No clinical module v1.4 work was introduced.

## Experience-first rule

The Phase 1 Product Shell is intentionally considered complete without speculative visual refinement.

> “I don't want to improve what I don't see. I want to experience SmileFlow first.”

Future observations may be collected during real product use and proposed separately; they do not reopen Phase 1 automatically.

## Completion decision

**PHASE 1 — PRODUCT SHELL: COMPLETE / ACCEPTED FOR PROGRESSION**

The next work should move to the next phase of the strict SmileFlow execution roadmap rather than continuing to polish the Product Shell.

## Next phase

**Phase 2 — Core Data**

The next immediate gate is the Phase 2 read-only architecture and dependency audit, beginning with the database architecture and runtime data contracts required to make the existing SmileFlow modules real.
